Basic Information
Basic information for TRAM2-AS1-209-13aa-1
Peptide Name TRAM2-AS1-209-13aa-1
Genome Position chr6:52579543-52579581[+]
Species Human
Peptide Sequence MTSAPANLLTTTS
Peptide Length 13
Unique No (TRAM2-AS1-201-13aa,TRAM2-AS1-202-13aa-1,TRAM2-AS1-203-13aa,TRAM2-AS1-204-13aa,TRAM2-AS1-205-13aa-1,TRAM2-AS1-206-13aa-2,TRAM2-AS1-207-13aa,TRAM2-AS1-208-13aa,TRAM2-AS1-210-13aa,TRAM2-AS1-211-13aa,TRAM2-AS1-212-13aa,TRAM2-AS1-213-13aa,TRAM2-AS1-214-13aa,TRAM2-AS1-215-13aa,TRAM2-AS1-216-13aa-1)
Grand Average of Hydropathicity 0.2769
Relative Molecular Mass 1523.8
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000225791;TRAM2-AS1
Transcript ID/Name ENST00000662922;TRAM2-AS1-209
Transcript Length 4041
Coding Ability 0.4318
DNA Sequence Corresponding to Peptide ATGACATCAGCCCCTGCTAATCTCTTGACTACAACCTCA
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :